HUM Company Profile and Key Details
Humana Inc.
HUM Stock Price Chart
Stock Price Today
Humana Inc. (HUM) stock declined over -2.74%, trading at $266.80 on NYSE, down from the previous close of $274.33. The stock opened at $272.74, fluctuating between $259.07 and $272.74 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Company Information
| Employees | 67600 |
| Beta | 0.52 |
| Sales or Revenue | $106.44B |
| 5Y Sales Change% | 1.075% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Healthcare Plans |
Frequently Asked Questions
Humana Inc. (NYSE: HUM) stock price is $266.80 in the last trading session. During the trading session, HUM stock reached the peak price of $272.74 while $259.07 was the lowest point it dropped to. The percentage change in HUM stock occurred in the recent session was -2.74% while the dollar amount for the price change in HUM stock was -$7.53.
The NYSE listed HUM is part of Medical - Healthcare Plans industry that operates in the broader Healthcare sector. Humana Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Bruce Dale Broussard
Pres, Chief Executive Officer & Director
Ms. Susan Marie Diamond
Chief Financial Officer
Mr. Timothy S. Huval
Chief Admin. Officer
Mr. Joseph C. Ventura
Chief Legal Officer
Mr. Timothy Alan Wheatley
Advisor
Mr. Sam M. Deshpande
Chief Information Officer
Mr. John-Paul W. Felter
Senior Vice President, Chief Accounting Officer, Principal Accounting Officer & Controller
Dr. William Kevin Fleming Pharm.D., PharmD, RPh
Chief Corporation Affairs Officer & Segment Pres of Pharmacy Solutions
Mr. John-Paul William Felter
Senior Vice President, Chief Accounting Officer, Principal Accounting Officer & Controller
Mr. Samir M. Deshpande
Chief Information Officer
Lisa M. Stoner
Vice President of Investor Relations
Amy Fry
Senior Vice President of Corporation Communications
Dr. Vishal Agrawal
Chief Strategy & Corporation Devel. Officer
HUM's closing price is 25.08% higher than its 52-week low of $213.31 where as its distance from 52-week high of $406.46 is -34.36%.
Number of HUM employees currently stands at 67,600.
Official Website of HUM is: https://www.humana.com
HUM could be contacted at phone 502 580 1000 and can also be accessed through its website. HUM operates from Humana Building, Louisville, KY 40202, United States.
HUM stock volume for the day was 2.57M shares. The average number of HUM shares traded daily for last 3 months was 1.65M.
The market value of HUM currently stands at $32.13B with its latest stock price at $266.80 and 120.41M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com